Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice

Table 1

The VA at baseline, 1 year, and 2 years.

VA, mean ± SD (median; range) (ETDRS letters)
	Baseline	1 year	Change from baseline at 1 year	2 years	Change from baseline at 2 years	value
All eyes (n = 123)	60.9 ± 15.2 (63; 7–85)	62.9 ± 15.3 (66; 13–85)	+2.2 ± 14.5 (1; −41–48)	62.9 ± 16.9 (65; 4–85)	+2.1 ± 16.8 (2; −53–52)	0.47
Eyes with baseline VA <70 letters (n = 77)	52.1 ± 12.3 (54; 7–69)	57.3 ± 16.0 (59; 13–85)	+5.3 ± 16.7 (4; −41–48)	57.6 ± 17.4 (60; 4–85)	+5.7 ± 17.9 (5; −52–52)	0.017
Eyes with baseline VA ≥70 letters (n = 46)	75.6 ± 4.6 (75; 70–85)	72.4 ± 7.6 (72.5; 58–85)	−2.9 ± 7.4 (−2; −21–10)	71.7 ± 11.9 (75; 32–85)	−3.9 ± 12.6 (−2; −53–11)	0.11

Legend: VA = visual acuity.